Analyst Coverage

Submenu

Firm	Analyst
Barclays	Etzer Darout, PhD
BofA Securities	Jason Zemansky, Ph.D.
Brookline Capital Markets	Leah Cann
Cantor Fitzgerald	Li Watsek
Citizens	Reni Benjamin, Ph.D.
H.C. Wainwright & Co.	Joseph Pantginis, Ph.D.
Guggenheim	Brad Canino
Jefferies	Roger Song, M.D., CFA
Leerink Partners	Jonathan Chang, Ph.D., CFA
LifeSci Capital	Charles Zhu, Ph.D.
Mizuho Securities	Salim Syed
TD Cowen	Phil Nadeau, Ph.D.
UBS	David Dai
Wedbush	Robert Driscoll, Ph.D.

Kura Oncology, Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Kura Oncology, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Kura Oncology, Inc. or its management. Kura Oncology, Inc. does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.